Life Science & Technology Weekly 128 – First Chronic Hepatitis B Patient Dosed in China in a Phase I Trial of T101 (Transgene’s TG1050 Technology) Jan 18, 2018 Life Science, Technology
First Chronic Hepatitis B Patient Dosed in China in a Phase I Trial of T101 (Transgene’s TG1050 Technology) Jan 17, 2018 Life Science
Amarin Announces Commencement of VASCEPA Clinical Development in Mainland China Jan 17, 2018 Life Science
Exclusive: J&J attracts Chinese interest for diabetes business in potential $3-4 billion deal – sources Jan 17, 2018 Life Science
Xbrane Biopharma Clarifies Information Regarding Letter of Intent With CR Pharma Considering Xlucane Jan 16, 2018 Life Science
China’s Hua Medicine mulls Hong Kong IPO as diabetes drug enters crucial clinical trial phase Jan 12, 2018 Life Science
Resverlogix Receives FDA Protocol Acceptance for the Ongoing Phase 3 BETonMACE Trial Jan 11, 2018 Life Science
BeiGene And Mirati Therapeutics Announce Exclusive License Agreement For Sitravatinib In The Asia Pacific Region Jan 9, 2018 Life Science
